Zepbound outperformed Wegovy for weight loss in a new clinical trial funded by Eli Lilly & Co., Zepbound's maker.
Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.
Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr.
Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?
Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...
The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.